Sign in
PLUR Stock Price, Chart, Stats & News
Pluri Inc.
Save
18.16M
Market cap
–
Current P/E
3.63x
Forward P/E
PLUR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 21.28% |
Operating margin | -1857.88% |
Pretax margin | -2026.06% |
Net margin | -1952.05% |
Effective tax rate | 0.08% |
ROA | -85.43% |
ROE | 280.42% |
D/E | -2.79x |
Interest coverage ratio | -27.49x |
PLUR valuation
P/E | – |
P/S | 19.76x |
P/B | -2.05x |
P/CF | -1.49x |
P/FCF | -1.20x |
P/OCF | -1.49x |
PEG | 0.21x |
EV multiple | 0.36x |
About
Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology.
Similar securities
Based on sector and market capitalization
Report issue